These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28748662)

  • 1. Repeated administration of high-dose depot medroxyprogesterone acetate does not alter SHIV
    Srinivasan P; Zhang J; Dinh CT; Teller RS; McNicholl JM; Kiser PF; Herold BC; Smith JM
    J Med Primatol; 2017 Aug; 46(4):129-136. PubMed ID: 28748662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologic doses of depot-medroxyprogesterone acetate do not increase acute plasma simian HIV viremia or mucosal virus shedding in pigtail macaques.
    Radzio J; Hanley K; Mitchell J; Ellis S; Deyounks F; Jenkins LT; Hanson D; Heneine W; García-Lerma JG
    AIDS; 2014 Jun; 28(10):1431-9. PubMed ID: 24759208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of depot medroxyprogesterone acetate on tenofovir alafenamide in rhesus macaques.
    Daly MB; Sterling M; Holder A; Dinh C; Nishiura K; Khalil G; García-Lerma JG; Dobard C
    Antiviral Res; 2021 Feb; 186():105001. PubMed ID: 33385420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Hormonal Contraception on Pharmacokinetics of Vaginal Tenofovir in Healthy Women: Increased Tenofovir Diphosphate in Injectable Depot Medroxyprogesterone Acetate Users.
    Thurman AR; Schwartz JL; Brache V; Chen BA; Chandra N; Kashuba ADM; Weiner DH; Mauck C; Doncel GF
    J Acquir Immune Defic Syndr; 2019 Jan; 80(1):79-88. PubMed ID: 30212395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Depot Medroxyprogesterone Acetate Dose That Models Human Use and Its Effect on Vaginal SHIV Acquisition Risk.
    Butler K; Ritter JM; Ellis S; Morris MR; Hanson DL; McNicholl JM; Kersh EN
    J Acquir Immune Defic Syndr; 2016 Aug; 72(4):363-71. PubMed ID: 27355414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenofovir disoproxil fumarate intravaginal ring protects high-dose depot medroxyprogesterone acetate-treated macaques from multiple SHIV exposures.
    Smith JM; Srinivasan P; Teller RS; Lo Y; Dinh CT; Kiser PF; Herold BC
    J Acquir Immune Defic Syndr; 2015 Jan; 68(1):1-5. PubMed ID: 25321184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial.
    Vincent KL; Moss JA; Marzinke MA; Hendrix CW; Anton PA; Pyles RB; Guthrie KM; Dawson L; Olive TJ; Butkyavichene I; Churchman SA; Cortez JM; Fanter R; Gunawardana M; Miller CS; Yang F; Rosen RK; Vargas SE; Baum MM
    PLoS Med; 2018 Sep; 15(9):e1002655. PubMed ID: 30265679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An intravaginal ring that releases three antiviral agents and a contraceptive blocks SHIV-RT infection, reduces HSV-2 shedding, and suppresses hormonal cycling in rhesus macaques.
    Derby N; Aravantinou M; Kenney J; Ugaonkar SR; Wesenberg A; Wilk J; Kizima L; Rodriguez A; Zhang S; Mizenina O; Levendosky K; Cooney ML; Seidor S; Gettie A; Grasperge B; Blanchard J; Piatak M; Lifson JD; Fernández-Romero J; Zydowsky TM; Robbiani M
    Drug Deliv Transl Res; 2017 Dec; 7(6):840-858. PubMed ID: 28600625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the depot medroxyprogesterone acetate injectable and levonorgestrel implant on HIV genital shedding: a randomized trial.
    Chinula L; Nelson JAE; Wiener J; Tang JH; Hurst S; Tegha G; Msika A; Ellington S; Hosseinipour MC; Mataya R; Haddad LB; Kourtis AP
    Contraception; 2018 Sep; 98(3):193-198. PubMed ID: 29746813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depot Medroxyprogesterone Acetate and the Vaginal Microbiome as Modifiers of Tenofovir Diphosphate and Lamivudine Triphosphate Concentrations in the Female Genital Tract of Ugandan Women: Implications for Tenofovir Disoproxil Fumarate/Lamivudine in Preexposure Prophylaxis.
    Nicol MR; Eneh P; Nakalega R; Kaiser T; Kabwigu S; Isingel E; Beksinska M; Sykes C; Fowler MG; Brown TT; Staley C; Kiweewa Matovu F
    Clin Infect Dis; 2020 Apr; 70(8):1717-1724. PubMed ID: 31131846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depot-medroxyprogesterone acetate does not reduce the prophylactic efficacy of emtricitabine and tenofovir disoproxil fumarate in macaques.
    Radzio J; Hanley K; Mitchell J; Ellis S; Deyounks F; Jenkins L; Heneine W; García-Lerma JG
    J Acquir Immune Defic Syndr; 2014 Dec; 67(4):365-9. PubMed ID: 25202923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Depot Medroxyprogesterone Acetate and Tenofovir Disoproxil Fumarate/Emtricitabine on Peripheral Blood Mononuclear Cells and Cervical Tissue Susceptibility to HIV Infection and Pharmacokinetics.
    Coleman JS; Diniz CP; Fuchs EJ; Marzinke MA; Aung W; Bakshi RP; Farzadegan H; Bream JH; Nilles TL; Hudson S; Bumpus NN; Schwartz GJ; Rosenblum MA; Rooney JF; Hendrix CW
    J Acquir Immune Defic Syndr; 2023 Jan; 92(1):89-96. PubMed ID: 36305827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings.
    Thurman AR; Schwartz JL; Ravel J; Gajer P; Marzinke MA; Yousefieh N; Anderson SM; Doncel GF
    PLoS One; 2019; 14(5):e0217229. PubMed ID: 31107913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges.
    Smith JM; Rastogi R; Teller RS; Srinivasan P; Mesquita PM; Nagaraja U; McNicholl JM; Hendry RM; Dinh CT; Martin A; Herold BC; Kiser PF
    Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16145-50. PubMed ID: 24043812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase 1 randomized placebo-controlled safety and pharmacokinetic trial of a tenofovir disoproxil fumarate vaginal ring.
    Keller MJ; Mesquita PM; Marzinke MA; Teller R; Espinoza L; Atrio JM; Lo Y; Frank B; Srinivasan S; Fredricks DN; Rabe L; Anderson PL; Hendrix CW; Kiser PF; Herold BC
    AIDS; 2016 Mar; 30(5):743-51. PubMed ID: 26605514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV Exposures.
    Srinivasan P; Moss JA; Gunawardana M; Churchman SA; Yang F; Dinh CT; Mitchell JM; Zhang J; Fanter R; Miller CS; Butkyavichene I; McNicholl JM; Smith TJ; Baum MM; Smith JM
    PLoS One; 2016; 11(6):e0157061. PubMed ID: 27275923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic evaluation of tenofovir disoproxil fumarate released from an intravaginal ring in pigtailed macaques after 6 months of continuous use.
    Srinivasan P; Dinh C; Zhang J; Pau CP; McNicholl JM; Lo Y; Herold BC; Teller R; Kiser P; Smith JM
    J Med Primatol; 2014 Oct; 43(5):364-9. PubMed ID: 25379594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestin-based contraception regimens modulate expression of putative HIV risk factors in the vaginal epithelium of pig-tailed Macaques.
    Bosinger SE; Tharp GK; Patel NB; Zhao C; Payne TL; Dietz Ostergaard S; Butler K; Ellis S; Johnson RL; Kersh EN; McNicholl JM; Vishwanathan SA
    Am J Reprod Immunol; 2018 Oct; 80(4):e13029. PubMed ID: 30076667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramuscular depot medroxyprogesterone acetate accentuates bone loss associated with tenofovir disoproxil fumarate-containing antiretroviral therapy initiation in young women living with HIV (the BONE: CARE study): a prospective cohort study in Uganda.
    Kiweewa Matovu F; Kiwanuka N; Nabwana M; Scholes D; Musoke P; Glenn Fowler M; Beksinska ME; Pettifor JM; Brown TT;
    Lancet Glob Health; 2022 May; 10(5):e694-e704. PubMed ID: 35427526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and pharmacokinetics of intravaginal rings delivering tenofovir in pig-tailed macaques.
    Moss JA; Malone AM; Smith TJ; Butkyavichene I; Cortez C; Gilman J; Kennedy S; Kopin E; Nguyen C; Sinha P; Hendry RM; Guenthner P; Holder A; Martin A; McNicholl J; Mitchell J; Pau CP; Srinivasan P; Smith JM; Baum MM
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5952-60. PubMed ID: 22964245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.